Shionogi & Co., Ltd. (4507.T) stock analysis

In our weekly check, Shionogi & Co., Ltd. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 3, red flags: 3.

About Shionogi & Co., Ltd.

Shionogi & Co., Ltd. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Japan, listed on JPX as 4507.T.

What our checks show for 4507.T

Red flags

• The gross margin fell by 5.2 points, to 78.3%: costs are rising faster than prices.
• Analysts expect the net margin to shrink by 16.1 points from today's 46.8%.
• The stock has fallen as much as 65% from a peak. Would you have held through that?

Warning signs

• Analysts expect earnings per share to shrink about 3% a year.
• Recovering from its deepest fall took about 2.7 years.
• Return on capital (ROCE) is only 9%.

Strengths

• Net debt is only 1.4x a year of EBITDA: the balance sheet has room.
• Operating profit covers interest 14.2 times over.
• The net margin rose by 12.7 points over 5 years, to 46.8%.
• Earnings per share grew 14.4% a year over the last 3 years.
• Net profit grew 12.5% a year over the last 3 years.
• The company keeps 46.8% of its revenue as net profit.

Next earnings report: 2026-10-29

Similar companies

DIVISLAB.NS · TORNTPHARM.NS · SUNPHARMA.NS · 4523.T · LAURUSLABS.NS · LUPIN.NS

Questions

What grade does Shionogi & Co., Ltd. (4507.T) have?

In our weekly check, Shionogi & Co., Ltd. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 3, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 4507.T stock?

This week's biggest flags for Shionogi & Co., Ltd.: Gross margin falling, Margins expected to shrink, Deep past fall. In total 6 of 25 checks show a warning or a red flag.

What does Shionogi & Co., Ltd. do?

Shionogi & Co., Ltd. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Japan, listed on JPX as 4507.T.

When does Shionogi & Co., Ltd. report earnings next?

The next earnings report is expected on 2026-10-29. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis